DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Januvia (Sitagliptin) - Current Clinical Trials

 
 



Januvia Related Clinical Trials

A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266) [Terminated]

The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects [Active, not recruiting]

A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081) [Completed]

Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes [Recruiting]

Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function [Active, not recruiting]

A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253) [Completed]

A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095) [Completed]

Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM [Completed]

Sitagliptin in Prevention of Type 2 Diabetes Mellitus [Not yet recruiting]

Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083) [Recruiting]

A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178) [Completed]

A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED) [Completed]

Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes [Completed]

Sitagliptin and Endothelial Dysfunction [Recruiting]

The Role of P-glycoprotein in Sitagliptin Clinical Pharmacology [Completed]

Treatment of Diabetes After Gastric Bypass With Sitagliptin [Recruiting]

Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121) [Completed]

Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans [Completed]

Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers [Terminated]

Sitagliptin and Brown Adipose Tissue [Not yet recruiting]

Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit [Not yet recruiting]

Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes [Recruiting]

A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211) [Terminated]

Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus [Completed]

Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005) [Active, not recruiting]

Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes Mellitus [Completed]

Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop [Recruiting]

Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes [Completed]

Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users [Not yet recruiting]

Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021) [Completed]

Beta-Cell Function and Sitagliptin Trial (BEST) [Completed]

A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296) [Completed]

A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229) [Completed]

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1) [Completed]

Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients With Heart Failure [Completed]

Sitagliptin in Renal Transplant Recipients [Completed]

A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110) [Completed]

Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome [Completed]

Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism [Completed]

Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313) [Completed]

Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea [Completed]

Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial. [Recruiting]

Januvia Re-examination Study (MK-0431-181) [Completed]

MK-3102 Phase III Clinical Trial - Placebo- and Sitagliptin-controlled Monotherapy Study in Japanese Participants With Type 2 Diabetes Mellitis (MK-3102-020) [Completed]

MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2) [Completed]

Correlation Between Plasma- and Endothelial DPP-4 Activity [Completed]

Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant [Active, not recruiting]

Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128) [Completed]

A Post Marketing Safety Study of Sitagliptin (JANUVIAŽ) (MK-0431-234) [Completed]

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251) [Completed]

Predictive Parameters for Efficacy of Sitagliptin and Metformin Combination [Completed]

A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048) [Completed]

Sitagliptin for Reducing Inflammation and Immune Activation [Not yet recruiting]

Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant [Recruiting]

Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy [Completed]

A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes [Recruiting]

A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254) [Completed]

Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation [Enrolling by invitation]

Effects of Sitagliptin on Gastric Emptying in Healthy Subjects [Completed]

Sitagliptin Added-on to Insulin Study (0431-051) [Completed]

Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery [Recruiting]

A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170) [Recruiting]

A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus [Completed]

Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105) [Completed]

Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment [Completed]

Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin Treatment [Completed]

Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260) [Completed]

Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122) [Completed]

Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome [Completed]

MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104) [Completed]

Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus [Completed]

Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052) [Completed]

Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130) [Completed]

Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial [Recruiting]

Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM [Not yet recruiting]

Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED) [Completed]

The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus [Completed]

Sitagliptin Dose Determination Study [Completed]

Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801) [Completed]

Study of the Bioequivalence of Two Tablet Forms of MK0431 (0431-027) [Completed]

Sitagliptin and HIV [Completed]

Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes [Terminated]

MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED) [Completed]

Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery [Not yet recruiting]

A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes [Completed]

24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years [Completed]

Changes in Bone Turnover With Increased Incretin Hormone Exposure [Recruiting]

Sitagliptin in the Elderly [Completed]

Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic Fibrosis [Recruiting]

Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes [Active, not recruiting]

An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED) [Completed]

Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases [Recruiting]

Sitagliptin in Cystic Fibrosis-Related Diabetes [Terminated]

ALPHA Sitagliptin Add on to Metformin (0431-103) [Completed]

Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263) [Completed]

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1) [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017